A146 THE EFFECTIVENESS OF USTEKINUMAB DOSE ESCALATION IN PATIENTS WITH ULCERATIVE COLITIS

BACKGROUND: Ustekinumab (UST), an IgG1 antibody that targets IL-12/23, is an effective and safe treatment option for patients with inflammatory bowel disease (IBD). Cohort studies have shown that dose escalation is an effective strategy for reinducing and maintaining remission in Crohn’s disease pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Albino, L, Rosentreter, R, Lu, C, Siffledeen, J, Dieleman, L A, Ma, C, Baugmart, D C, Du, L, Halloran, B, Kroeker, K, Peerani, F, Wong, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Poster of Distinction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859317/
http://dx.doi.org/10.1093/jcag/gwab049.145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859317/
http://dx.doi.org/10.1093/jcag/gwab049.145

Ejemplares similares